RxDoctor Payments Data

Lisa Mazzullo

Chicago, ILNPI 1952354342

Payments from drug & device makers

$2,243in general payments, 2019–2025

Across 114 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$651
  • Exeltis, USA Inc.$198
  • Astellas Pharma US Inc$161
  • Bayer$152
  • Mayne Pharma Commercial LLC$140
  • Merck$119
  • plus $823 from 16 others

What the payments were for

  • Food & beverage$2,21799%
  • Education$261%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol72$8,668
Estradiol (Twice Weekly)Estradiol13$1,092
ValacyclovirValacyclovir Hcl11$760
Clobetasol Propionate14$719
Fluoxetine Hcl12$300
Alprazolam11$11

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →